The effects of topiramate on lipopolysaccharide (LPS)-induced proinflammatory cytokine release from primary rat microglial cell cultures
- 1 November 2016
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 127, 352-357
Abstract
No abstract availableKeywords
Funding Information
- Medical University of Lodz (502-03/3-011-01/502-34-007, 503/3-011-01/503-06-300, 503/3-011-01/503-01)
- European Regional Development Fund (POIG.01.01.02-10-107/09)
This publication has 44 references indexed in Scilit:
- Glia and epilepsy: excitability and inflammationTrends in Neurosciences, 2013
- Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microgliaJournal of Neuroinflammation, 2013
- Cytokines and brain excitabilityFrontiers in Neuroendocrinology, 2012
- Antiepileptic drugs and the immune systemEpilepsia, 2011
- The role of inflammation in epilepsyNature Reviews Neurology, 2010
- Weight Reducing and Metabolic Effects of Topiramate in Patients with Migraine – an Observational StudyExperimental and Clinical Endocrinology & Diabetes, 2010
- IL‐6 Levels in Migraine Patients Receiving TopiramatePain Practice, 2009
- Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytesJournal of Neuroscience Research, 2008
- Intranasal administration of human IL-6 increases the severity of chemically induced seizures in ratsNeuroscience Letters, 2004
- Profound increase in sensitivity to glutamatergic‐ but not cholinergic agonist‐induced seizures in transgenic mice with astrocyte production of IL‐6Journal of Neuroscience Research, 2003